|
1
|
Selvarajah S, Yoshimoto M, Ludkovski O,
Park PC, Bayani J, Thorner P, Maire G, Squire JA and Zielenska M:
Genomic signatures of chromosomal instability and osteosarcoma
progression detected by high resolution array CGH and interphase
FISH. Cytogenet Genome Res. 122:5–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Selvarajah S, Yoshimoto M, Maire G,
Paderova J, Bayani J, Squire JA and Zielenska M: Identification of
cryptic microaberrations in osteosarcoma by high-definition
oligonucleotide array comparative genomic hybridization. Cancer
Genet Cytogenet. 179:52–61. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang J, Liu S, Shi J, Li J, Wang S, Liu H,
Zhao S, Duan K, Pan X and Yi Z: The role of miRNA in the diagnosis,
prognosis, and treatment of osteosarcoma. Cancer Biother
Radiopharm. 34:605–613. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anderson ME: Update on survival in
osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song K, Song J, Lin K, Chen F, Ma X, Jiang
J and Li F: Survival analysis of patients with metastatic
osteosarcoma: A Surveillance, Epidemiology, and End Results
population-based study. Int Orthop. 43:1983–1991. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ouyang L, Liu P, Yang S, Ye S, Xu W and
Liu X: A three-plasma miRNA signature serves as novel biomarkers
for osteosarcoma. Med Oncol. 30:3402013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J, Yan YG, Wang C, Zhang SJ, Yu XH
and Wang WJ: MicroRNAs in osteosarcoma. Clin Chim Acta. 444:9–17.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hesse E and Taipaleenmäki H: MicroRNAs in
bone metastasis. Curr Osteoporos Rep. 17:122–128. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qu K, Wang Z, Lin XL, Zhang K, He XL and
Zhang H: MicroRNAs: Key regulators of endothelial progenitor cell
functions. Clin Chim Acta. 448:65–73. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hironaka-Mitsuhashi A, Otsuka K,
Gailhouste L, Sanchez Calle A, Kumazaki M, Yamamoto Y, Fujiwara Y
and Ochiya T: miR-1285-5p/TMEM194A axis affects cell proliferation
in breast cancer. Cancer Sci. 111:395–405. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qin S, Ai F, Ji WF, Rao W, Zhang HC and
Yao WJ: miR-19a promotes cell growth and tumorigenesis through
targeting SOCS1 in gastric cancer. Asian Pac J Cancer Prev.
14:835–840. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen J and Chen Z: Downregulation of
miR-19a inhibits the proliferation and promotes the apoptosis of
osteosarcoma cells by regulating the JAK2/STAT3 pathway. Oncol
Lett. 20:1732020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun L, Wang L, Luan S, Jiang Y and Wang Q:
miR-429 inhibits osteosarcoma progression by targeting HOXA9
through suppressing Wnt/β-catenin signaling pathway. Oncol Lett.
20:2447–2455. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao J, Tan W, Wu W, Ye R, Li Y and Chen Y:
Effects of miR-432 and miR-548c-3p on the proliferation and
invasion of osteosarcoma cells. J BUON. 25:1562–1568.
2020.PubMed/NCBI
|
|
16
|
Zhou L, Lu Y, Liu JS, Long SZ, Liu HL,
Zhang J and Zhang T: The role of miR-21/RECK in the inhibition of
osteosarcoma by curcumin. Mol Cell Probes. 51:1015342020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Shi S, Zhang Q, Dong H and Zhang
J: MicroRNA-206 upregulation relieves circTCF25-induced
osteosarcoma cell proliferation and migration. J Cell Physiol
jcp.29570. 2020.
|
|
18
|
Liao Y, Cao L, Wang F and Pang R:
miR-605-5p promotes invasion and proliferation by targeting TNFAIP3
in non-small-cell lung cancer. J Cell Biochem. 121:779–787. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou YJ, Yang HQ, Xia W, Cui L, Xu RF, Lu
H, Xue Z, Zhang B, Tian ZN, Cao YJ, et al: Down-regulation of
miR-605 promotes the proliferation and invasion of prostate cancer
cells by up-regulating EN2. Life Sci. 190:7–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang C, Wan J, Long F, Liu Q and He H:
Identification and validation of microRNAs and their targets
expressed in osteosarcoma. Oncol Lett. 18:5628–5636.
2019.PubMed/NCBI
|
|
21
|
Cates JM: Comparison of the AJCC, MSTS,
and modified spanier systems for clinical and pathologic staging of
osteosarcoma. Am J Surg Pathol. 41:405–413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia G, Wang Y, Yu Y, Li Z and Wang X: Long
non coding RNA NR2F1 AS1 facilitates the osteosarcoma cell
malignant phenotype via the miR 485 5p/miR 218 5p/BIRC5 axis. Oncol
Rep. 44:1583–1595. 2020.PubMed/NCBI
|
|
24
|
Fan H, Liu T, Tian H and Zhang S: TUSC8
inhibits the development of osteosarcoma by sponging miR 197 3p and
targeting EHD2. Int J Mol Med. 46:1311–1320. 2020.PubMed/NCBI
|
|
25
|
Wang L, Jiang J, Sun G, Zhang P and Li Y:
Effects of lncRNA TUSC7 on the malignant biological behavior of
osteosarcoma cells via regulation of miR-375. Oncol Lett.
20:1332020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feliciano A, Garcia-Mayea Y, Jubierre L,
Mir C, Hummel M, Castellvi J, Hernández-Losa J, Paciucci R, Sansano
I, Sun Y, et al: miR-99a reveals two novel oncogenic proteins E2F2
and EMR2 and represses stemness in lung cancer. Cell Death Dis.
8:e31412017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zuberi M, Khan I, Mir R, Gandhi G, Ray PC
and Saxena A: Utility of serum miR-125b as a diagnostic and
prognostic indicator and its alliance with a panel of tumor
suppressor genes in epithelial ovarian cancer. PLoS One.
11:e01539022016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mousa H, Yuan M, Zhang X, Li X, Shopit A,
Almoiliqy M, Alshwmi M, Al-Dherasi A, Xu Y and Zuo Y: MicroRNA-4316
inhibits gastric cancer proliferation and migration via directly
targeting VEGF-A. Cancer Cell Int. 20:622020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang D, Sun W, Zhou Y, Li P, Chen F, Chen
H, Xia D, Xu E, Lai M, Wu Y, et al: Mutations of key driver genes
in colorectal cancer progression and metastasis. Cancer Metastasis
Rev. 37:173–187. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wei F, Wang M, Li Z, Wang Y and Zhou Y:
miR 593 inhibits proliferation and invasion and promotes apoptosis
in non small cell lung cancer cells by targeting SLUG associated
signaling pathways. Mol Med Rep. 20:5172–5182. 2019.PubMed/NCBI
|
|
31
|
Sun R, Shen J, Gao Y, Zhou Y, Yu Z,
Hornicek F, Kan Q and Duan Z: Overexpression of EZH2 is associated
with the poor prognosis in osteosarcoma and function analysis
indicates a therapeutic potential. Oncotarget. 7:38333–38346. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang W, Wei L, Sheng W, Kang B, Wang D
and Zeng H: miR-1225-5p Functions as a tumor suppressor in
osteosarcoma by targeting Sox9. DNA Cell Biol. 39:78–91. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Huang H and Li Y: Knocking down
miR-384 promotes growth and metastasis of osteosarcoma MG63 cells
by targeting SLBP. Artif Cells Nanomed Biotechnol. 47:1458–1465.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li J, Tian F, Li D, Chen J, Jiang P, Zheng
S, Li X and Wang S: miR-605 represses PSMD10/Gankyrin and inhibits
intrahepatic cholangiocarcinoma cell progression. FEBS Lett.
588:3491–3500. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen L and Cao Y, Rong D, Wang Y and Cao
Y: MicroRNA-605 functions as a tumor suppressor by targeting INPP4B
in melanoma. Oncol Rep. 38:1276–1286. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Danesh H, Hashemi M, Bizhani F, Hashemi SM
and Bahari G: Association study of miR-100, miR-124-1, miR-218-2,
miR-301b, miR-605, and miR-4293 polymorphisms and the risk of
breast cancer in a sample of Iranian population. Gene. 647:73–78.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pan MZ, Song YL and Gao F: miR-605-3p
inhibits malignant progression of prostate cancer by up-regulating
EZH2. Eur Rev Med Pharmacol Sci. 23:8795–8805. 2019.PubMed/NCBI
|
|
38
|
Zhou W and Li R: MicroRNA-605 inhibits the
oncogenicity of non-small-cell lung cancer by directly targeting
Forkhead Box P1. OncoTargets Ther. 12:3765–3777. 2019. View Article : Google Scholar
|
|
39
|
Qiu C, Li S, Sun D and Yang S: lncRNA PVT1
accelerates progression of non-small cell lung cancer via targeting
miRNA-526b/EZH2 regulatory loop. Oncol Lett. 19:1267–1272.
2020.PubMed/NCBI
|
|
40
|
Chen Z, Du Y, Liu X, Chen H, Weng X, Guo
J, Wang M, Wang X and Wang L: EZH2 inhibition suppresses bladder
cancer cell growth and metastasis via the JAK2/STAT3 signaling
pathway. Oncol Lett. 18:907–915. 2019.PubMed/NCBI
|
